What is it and how is it used?

OLANZAPINE NEOPHARMA belongs to a group of medicines called antipsychotics.

OLANZAPINE NEOPHARMA is used to treat a disease with symptoms such as hearing, seeing or sensing things which are not there, mistaken beliefs, unusual suspiciousness, and becoming withdrawn. People with this disease may also feel depressed, anxious or tense.

OLANZAPINE NEOPHARMA is used to treat a condition with symptoms such as feeling "high", having excessive amounts of energy, needing much less sleep than usual, talking very quickly with racing ideas and sometimes severe irritability. It is also a mood stabiliser that prevents further occurrences of the disabling high and low (depressed) extremes of mood associated with this condition.

What do you have to consider before using it?

Do not take OLANZAPINE NEOPHARMA

  • if you are allergic (hypersensitive) to olanzapine or any of the other ingredients of OLANZAPINE NEOPHARMA.An allergic reaction may be recognised as a rash, itching, a swollen face, swollen lips or shortness of breath. If this has happened to you, tell your doctor.
  • if you have been previously diagnosed with eye problems such as certain kinds of glaucoma (increased pressure in the eye) .
Take special care with OLANZAPINE NEOPHARMA

  • Medicines of this type may cause unusual movements mainly of the face or tongue. If this happens after you have been given OLANZAPINE NEOPHARMA tell your doctor.
  • Very rarely, medicines of this type cause a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness. If this happens, contact your doctor at once.
  • The use of OLANZAPINE NEOPHARMA in elderly patients with dementia is not recommended as it may have serious side effects.

If you suffer from any of the following illnesses tell your doctor as soon as possible:

  • Diabetes
  • Heart disease
  • Liver or kidney disease
  • Parkinson?s disease
  • Epilepsy
  • Prostate problems
  • A blocked intestine (Paralytic ileus)
  • Blood disorders
  • Stroke or ?mini? stroke (temporary symptoms of stroke)

If you suffer from dementia, you or your carer/relative should tell your doctor if you have ever had a stroke or ?mini? stroke.

As a routine precaution, if you are over 65 years your blood pressure may be monitored by your doctor.

OLANZAPINE NEOPHARMA is not for patients who are under 18 years.

Taking other medicines

Only take other medicines while you are on OLANZAPINE NEOPHARMA if your doctor tells you that you can. You might feel drowsy if OLANZAPINE NEOPHARMA is taken in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers).

You should tell your doctor if you are taking fluvoxamine (an antidepressant or ciprofloxacin (an antibiotic), as it may be necessary to change your OLANZAPINE NEOPHARMA dose.

Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Especially tell your doctor if you are taking medicines for Parkinson?s disease.

Taking OLANZAPINE NEOPHARMA with food and drink

Do not drink any alcohol if you have been given OLANZAPINE NEOPHARMA as OLANZAPINE NEOPHARMA and alcohol together may make you feel drowsy.

Pregnancy and breast-feeding

Tell your doctor as soon as possible if you are pregnant or think you may be pregnant. You should not take this medicine when pregnant, unless you have discussed this with your doctor. You should not be given this medicine when breast-feeding, as small amounts of OLANZAPINE NEOPHARMA can pass into breast milk.

Driving and using machines

There is a risk of feeling drowsy when you are given OLANZAPINE NEOPHARMA. If this happens do not drive or operate any tools or machines. Tell your doctor.

Important information about some of the ingredients of OLANZAPINE NEOPHARMA OLANZAPINE NEOPHARMA contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

How is it used?

Always take OLANZAPINE NEOPHARMA exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

Your doctor will tell you how many OLANZAPINE NEOPHARMA tablets to take and how long you should continue to take them. The daily dose of OLANZAPINE NEOPHARMA is between 5 and 20 mg. Consult your doctor if your symptoms return but do not stop taking OLANZAPINE NEOPHARMA unless your doctor tells you to.

You should take your OLANZAPINE NEOPHARMA tablets once a day following the advice of your doctor. Try to take your tablets at the same time each day. It does not matter whether you take them with or without food. OLANZAPINE NEOPHARMA coated tablets are for oral use. You should swallow the OLANZAPINE NEOPHARMA tablets whole with water.

If you take more OLANZAPINE NEOPHARMA than you should

Patients who have taken more OLANZAPINE NEOPHARMA than they should, have experienced the following symptoms: rapid beating of the heart, agitation/aggressiveness, problems with speech, unusual movements (especially of the face or tongue) and reduced level of consciousness. Other symptoms may be: acute confusion, seizures (epilepsy), coma, a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness, slowing of the breathing rate, aspiration, high blood pressure or low blood pressure, abnormal rhythms of the heart. Contact your doctor or hospital straight away. Show the doctor your pack of tablets.

If you forget to take OLANZAPINE NEOPHARMA

Take your tablets as soon as you remember. Do not take two doses in one day.

If you stop taking OLANZAPINE NEOPHARMA

Do not stop taking your tablets just because you feel better. It is important that you carry on taking OLANZAPINE NEOPHARMA for as long as your doctor tells you.

If you suddenly stop taking OLANZAPINE NEOPHARMA, symptoms such as sweating, unable to sleep, tremor, anxiety or nausea and vomiting might occur. Your doctor may suggest you to reduce the dose gradually before stopping treatment.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

What are possible side effects?

Like all medicines, OLANZAPINE NEOPHARMA can cause side effects, although not everybody gets them.

Very common side effects: affect 1 user in 10

  • Weight gain.
  • Sleepiness.
  • Increases in the levels of prolactin in the blood.

Common side effects: affect 1 to 10 users in 100

  • Changes in the levels of some blood cells and circulating fats.
  • Increases in the level of sugars in the blood and urine.
  • Feeling more hungry.
  • Dizziness.
  • Restlessness.
  • Tremor.
  • Muscle stiffness or spasm (including eye movements).
  • Problems with speech.
  • Unusual movement (especially of the face or tongue).
  • Constipation.
  • Dry mouth.
  • Rash.
  • Loss of strength.
  • Extreme tiredness.
  • Water retention leading to swelling of the hands, ankles or feet.
  • In the early stages of treatment, some people may feel dizzy or faint (with a slow heart rate), especially when getting up from a lying or sitting position. This will usually pass on its own but if it does not, tell your doctor.
  • Sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.

Uncommon side effects: affect 1 to 10 users in 1,000

  • Slow heart rate.
  • Make you sensitive to sunlight.
  • Urinary incontinence.
  • Hair loss.
  • Absence or decrease in menstrual periods.
  • Changes in breasts in males and females such as an abnormal production of breast milk or abnormal growth.

Other possible side effects: frequency cannot be estimated from the available data.

  • Allergic reaction (e.g. swelling in the mouth and throat, itching, rash).
  • Diabetes or the worsening of diabetes, occasionally associated with ketoacidosis (ketones in the blood and urine) or coma.
  • Lowering of normal body temperature.
  • Seizures, usually associated with a history of seizures (epilepsy).
  • Combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness.
  • Spasms of the muscle of the eye causing rolling movement of the eye.
  • Abnormal rhythms of the heart.
  • Sudden unexplained death.
  • Blood clots such as deep venous thrombosis of the leg or blood clot on the lung.
  • Inflammation of the pancreas causing severe stomach pain, fever and sickness.
  • Liver disease appearing as yellowing of the skin and white parts of the eyes.
  • Muscle disease presenting as unexplained aches and pains.
  • Difficulty in passing urine.
  • Prolonged and/or painful erection.

While taking olanzapine, elderly patients with dementia may suffer from stroke, pneumonia, urinary incontinence, falls, extreme tiredness, visual hallucinations, a rise in body temperature, redness of the skin and have trouble walking. Some fatal cases have been reported in this particular group of patients.

In patients with Parkinson's disease OLANZAPINE NEOPHARMA may worsen the symptoms.

Rarely women taking medicines of this type for a long time have started to secrete milk and have missed periods or had irregular periods. If this persists tell your doctor. Very rarely babies born to mothers who have taken OLANZAPINE NEOPHARMA in the last stage of pregnancy (3 rd trimester) may have tremors, be sleepy or drowsy.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor.

How should it be stored?

Keep out of the reach and sight of children.

Do not use Olanzapine Neopharma after the expiry date which is stated on the carton after Exp. Store in the original package. Store below 30ºC.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

Further information

What Olanzapine Neopharmacontains

  • The active substance is olanzapine. Each Olanzapine Neopharma coated tablet contains either 2.5 mg, 5 mg, 7.5 mg, 10 mg or 15 mg of the active substance.
  • The other ingredients are:
  • Tablet core: lactose monohydrate (See also end of section 2 ? important information about some of the ingredients of Olanzapine Neopharma), maize starch, hydroxypropyl cellulose, magnesium stearate.
  • Tablet coat:
  • 2.5 mg, 5 mg, 7.5 mg and 10 mg tablets: Opadry white containing hypromellose (E464), titanium dioxide (E171), lactose monohydrate, polyethylene glycol 3000 and glycerol triacetate
  • 15 mg tablets: Opadry Blue containing hypromellose (E464), titanium dioxide (E171), polyethylene glycol 6000, indigo carmine aluminium lake (E132), brilliant blue FCF aluminium lake (E133) and iron oxide black (E172)

What OLANZAPINE NEOPHARMA looks like and contents of the pack

Olanzapine Neopharma 2.5 mg coated tablets are white, round, biconvex, coated tablets with ?2.5? debossed on one side and ?OLZ? on the other.

Olanzapine Neopharma 5 mg coated tablets are white, round, biconvex, coated tablets with ?OLZ 5? debossed on one side and ?NEO? on the other.

Olanzapine Neopharma 7.5 mg coated tablets are white, round, biconvex, coated tablets with ?OLZ 7.5? debossed on one side and ?NEO? on the other.

Olanzapine Neopharma 10 mg coated tablets are white, round, biconvex, coated tablets with ?OLZ 10? debossed on one side and ?NEO? on the other.

Olanzapine Neopharma 15 mg coated tablets are blue, elliptical, convex, coated tablets with ?NEO? debossed on one side and plain on the other side.

Olanzapine Neopharma 2.5 mg, 5 mg, 7.5 mg and 15 mg coated tablets are available in 28 and 56 blister packs.

Olanzapine Neopharma 10 mg coated tablets are available in 7, 28 and 56 blister packs.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder: Neopharma Limited, 57 High Street, Odiham, Hampshire, RG29 1LF, UK
Tel: +44 (0)1256 704110
Fax: +44 (0)1256 701144

Manufacturer: Neolab Limited, 57 High Street, Odiham, Hampshire, RG29 1LF, UK Tel: +44 (0)1256 704110
Fax: +44 (0)1256 701144

This leaflet was last approved in {MM/YYYY}.

Cookies help us deliver our services. By using our services, you agree to our use of cookies. OK